New York, United States
AposHealth is dedicated to transforming the field of musculoskeletal care, with a focus on improving mobility and wellbeing for individuals with related conditions. The company's flagship solution, Apos®, has received FDA clearance for the treatment of knee osteoarthritis, delivering temporary pain relief and also serving as a general wellness device for chronic lower back and hip pain.
Founded in 2004 and based in the United States, AposHealth has garnered significant attention within the Health Care and Sports industries. Its innovative approach, involving gait analysis, personalized medical devices, and customized treatment plans, has garnered remarkable success, with over 100,000 patients treated and an impressive 96% satisfaction rate.
The company recently secured a substantial $11.00M Series A investment from aMoon on 17 February 2020, propelling its mission to enhance the quality of life for individuals experiencing chronic knee, lower back, and hip pain globally.
Through its commitment to empowering individuals to move, live, and thrive, AposHealth is poised to continue making a significant impact in the realm of musculoskeletal wellness.
